| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/20/2001 | WO2001068649A1 Novel process for the preparation of a quinoline carboxylic acid derivative having a 7-(4-aminomethyl-3-oxime)pyrrolidine substituent |
| 09/20/2001 | WO2001068647A1 Medicaments against viral diseases |
| 09/20/2001 | WO2001068642A1 Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 09/20/2001 | WO2001068641A1 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viral diseases |
| 09/20/2001 | WO2001068640A1 Medicaments against viral diseases |
| 09/20/2001 | WO2001068639A1 Dihydropyrimidine-5-carboxylic acid esters and use thereof as medicaments against viral diseases |
| 09/20/2001 | WO2001068615A1 Quinazoline synthesis |
| 09/20/2001 | WO2001068614A2 5-substituted arylpyrimidines |
| 09/20/2001 | WO2001068609A1 1,2,3,4-tetrahydroisoquinoline derivatives |
| 09/20/2001 | WO2001068604A2 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| 09/20/2001 | WO2001068603A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 09/20/2001 | WO2001068594A1 Method for oxidizing a thioether group into a sulfoxide group |
| 09/20/2001 | WO2001068589A1 Acrylonitrile compounds and pest controllers |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068186A2 Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 09/20/2001 | WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 09/20/2001 | US20010023295 By reacting a 3-((alkyl, alkoxy, phenyl or heteroaryl)carbonylamino)thiophene with a ketone in the presence of an acid and reducing the reaction mixture; agricultural fungicides |
| 09/20/2001 | US20010023292 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example |
| 09/20/2001 | US20010023291 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 09/20/2001 | US20010023248 Antiinflammatory agents, central nervous system disorders |
| 09/20/2001 | DE10013126A1 New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 09/20/2001 | DE10013125A1 New 4-dihalophenyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 09/20/2001 | DE10012824A1 New 6-hydroxyhydrocarbyl or 6-thiohydrocarbyl-dihydropyrimidine-5-carboxylic acid derivatives, useful for the treatment of viral infections, especially hepatitis B infections |
| 09/20/2001 | DE10012823A1 New alkyl-6-aminoalkyl-dihydropyrimidine-5-carboxylate derivatives, useful for the treatment of viral, especially hepatitis B, infections |
| 09/20/2001 | DE10012549A1 New heterocyclic-substituted dihydropyrimidine derivatives useful for treatment of viral infections, especially hepatitis B infections |
| 09/20/2001 | CA2373411A1 5-substituted arylpyrimidines |
| 09/19/2001 | EP1134219A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 09/19/2001 | EP1134215A1 2-oxo-imidazolidine-4-carboxylic acid hydroxamine compounds that inhibit matrix metalloproteinases |
| 09/19/2001 | EP1134214A1 Picolinamide derivatives and pest controllers containing the same as the active ingredient |
| 09/19/2001 | EP1134213A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides |
| 09/19/2001 | EP1133489A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 09/19/2001 | EP1133488A1 Propanoic acid derivatives as integrin inhibitors |
| 09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
| 09/19/2001 | EP1133475A1 Substituted benzo de]isoquinoline-1,3-diones |
| 09/19/2001 | EP0869954B1 Heterocyclic compounds for use in the treatment of neurogenic inflammation |
| 09/19/2001 | EP0839144B1 Piperazine derivatives as therapeutic agents |
| 09/19/2001 | EP0820443B1 Heterocyclic compounds for treating diabetes |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313854A Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 09/19/2001 | CN1313853A Oxindole derivatives as growth hormone releasers |
| 09/19/2001 | CN1313767A Carbamate and urea compositions and neurotrophic uses |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1071331C Anti-helicobacter acyl derivatives of azolones |
| 09/19/2001 | CN1071330C Anti-helicobacter urea and thiourea derivatives of azolones |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/18/2001 | US6291687 Used aspartyl protease inhibitors of human immunodeficiency virus (hiv) |
| 09/18/2001 | US6291683 N-arloxyethyl-alkylamines for the treatment of depression |
| 09/18/2001 | US6291679 Process for preparing benzoperhydroisoindole compounds |
| 09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 09/18/2001 | US6291510 Small molecule inhibitors of rotamase enzyme activity |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291504 Potent inhibitors of the class of enzymes known as cyclin dependent kinases |
| 09/18/2001 | US6291485 Treatment of post-ptca restenosis |
| 09/18/2001 | US6291481 Conditions related to a hampered or impaired gastric emptying and more generally to treat conditions related to a hampered or impaired gastrointestinal transit. |
| 09/18/2001 | US6291480 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 09/18/2001 | US6291478 Compounds of the benzylaminodiacetamide family, compositions comprising them, preparation process and uses |
| 09/18/2001 | US6291477 Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia |
| 09/18/2001 | US6291476 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 09/18/2001 | US6291467 Heteroaromatic derivatives |
| 09/18/2001 | US6291457 Compounds having cytokine inhibitory activity |
| 09/18/2001 | US6291453 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/18/2001 | US6291452 Cholecystokinin antagonists. |
| 09/18/2001 | US6291450 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 09/18/2001 | US6289745 High temperature insertion type flow element and mounting extension |
| 09/18/2001 | CA2236814C Quinoline and quinazoline compounds useful in therapy |
| 09/13/2001 | WO2001066542A1 Pyridonecarboxylic acid derivatives |
| 09/13/2001 | WO2001066540A1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 09/13/2001 | WO2001066539A1 Imidazol derivatives as raf kinase inhibitors |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066522A1 Acylated phenyl or pyridine herbicides |
| 09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 09/13/2001 | WO2001066520A1 Indole derivatives, process for preparation of the same and use thereof |
| 09/13/2001 | WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 09/13/2001 | WO2001066098A2 Therapeutic uses of ppar mediators |
| 09/13/2001 | WO2001030759A3 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 09/13/2001 | WO2001028993A3 Tyrosine kinase inhibitors |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | WO2000059886A3 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
| 09/13/2001 | WO2000059883A3 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate |
| 09/13/2001 | US20010021791 Cyclopropyl phenyl ketone compound |
| 09/13/2001 | US20010021777 Indane or dihydroindole derivatives |
| 09/13/2001 | US20010021775 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa |
| 09/13/2001 | US20010021716 Using agonist of nicotinergic acetylcholine receptors |
| 09/13/2001 | US20010021715 Gastrointestinal disorders |
| 09/13/2001 | CA2402315A1 Therapeutic uses of ppar mediators |
| 09/13/2001 | CA2402174A1 Indole derivatives, process for preparation of the same and use thereof |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/12/2001 | EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 09/12/2001 | EP1131321A2 Indole derivatives and their use as serotonin receptor ligands |
| 09/12/2001 | EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes |
| 09/12/2001 | EP1131316A2 Improved chemical process and pharmaceutical formulation |
| 09/12/2001 | EP1131315A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131313A1 Enantioselective alkylation of tricyclic compounds |
| 09/12/2001 | EP1131312A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 09/12/2001 | EP1131308A1 New piperazine and piperidine compounds |
| 09/12/2001 | EP1131302A1 Substituted 4-amino-2-aryl-cyclopenta d]pyrimidines, their production and use and pharmaceuticalreparations containing same |
| 09/12/2001 | EP1131297A1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131294A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |